Recombinant Mouse CCL22 Protein
| Cat.No. : | CCL22-2884M |
| Product Overview : | Recombinant Mouse CCL22 protein, was expressed in E. coli. |
- Specification
- Gene Information
- Related Products
| Source : | E. coli |
| Species : | Mouse |
| Form : | Lyophilized from a 0.2 µM filtered solution of 20 mM phosphate buffer,100 mM NaCl, pH 7.2 |
| Molecular Mass : | 7.8 kDa |
| Purity : | >95% as determined by SDS-PAGE and Coomassie blue staining |
| Concentration : | Resuspend the protein in the desired concentration in proper buffer |
| Gene Name : | Ccl22 chemokine (C-C motif) ligand 22 [ Mus musculus ] |
| Official Symbol : | CCL22 |
| Synonyms : | ABCD-1; DCBCK; MDC; Scya22 |
| Gene ID : | 20299 |
| mRNA Refseq : | NM_009137 |
| Protein Refseq : | NP_033163 |
Products Types
| ◆ Recombinant Protein | ||
| CCL22-1108P | Recombinant Pig CCL22 Protein, His-tagged | +Inquiry |
| CCL22-2887M | Active Recombinant Mouse Ccl22 Protein | +Inquiry |
| Ccl22-2034M | Recombinant Mouse Ccl22 Protein, Myc/DDK-tagged | +Inquiry |
| CCL22-0627H | Recombinant Human CCL22 Protein, GST-Tagged | +Inquiry |
| Ccl22-131M | Active Recombinant Mouse Ccl22 Protein | +Inquiry |
| ◆ Lysates | ||
| CCL22-7728HCL | Recombinant Human CCL22 293 Cell Lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (6)
Ask a questionThe expression of CCL22 gene is regulated by a variety of signaling pathways, including inflammatory factor-mediated signaling pathways, cytokine-mediated signaling pathways, and transcription factors.
Studies have shown that by interfering with the interaction of the CCL22 protein and its receptor CCR4, tumor growth, improve inflammatory response, and regulate autoimmune diseases can be inhibited. These findings provide potential application value for the development of corresponding therapeutic strategies.
A number of inhibitors or antagonists that interact with CCL22 proteins have been developed that block the binding of CCL22 to its receptor CCR4, thereby interfering with its biological function.
The mechanism of action of CCL22 protein in specific diseases can be studied through cell culture experiments, animal models, clinical samples, and related biochemical techniques.
There are complex interactions between CCL22 proteins and other chemokines. They may influence the migration and localization of immune cells by competing for receptors, mutual regulation of expression, etc.
Some studies have shown that in tumor immunotherapy, inhibiting the expression of CCL22 or interfering with its interaction with CCR4 can enhance the effect of immunotherapy and improve the survival rate of patients.
Ask a Question for All CCL22 Products
Required fields are marked with *
My Review for All CCL22 Products
Required fields are marked with *
Inquiry Basket
